Investing.com - Biomerica announced first quarter earnings that missed analysts' expectations on Tuesday and revenue that fell short of forecasts.
The company reported earnings per share of $-0.160 on revenue of $1.640. Analysts polled by Investing.com expected EPS of $-0.020 on revenue of $2.7M. .
Biomerica stock's are down 4.88% since the start of the year , down-from-52-week-high.
Biomerica follows other major Healthcare sector earnings this month
On Friday, UnitedHealth reported third quarter EPS of $5.79 on revenue of $80.9B, was in comparison to a forecasts for EPS of $5.43 on revenue of $80.52B.
Exelixis earnings beat analysts' expectations on Tuesday, August 9, 2022, with second quarter EPS of $0.22 on revenue of $419.43M. Investing.com analysts expected EPS of $0.203 on revenue of $391.03M
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar